Under Promise, Over Deliver
from Running Through Walls Hosted by Venrock, a venture capital firm
Venrock partners Andrew Gottesdiener and Nimish Shah sat down with Michael Henderson, CEO of Apogee Therapeutics, to talk about selling Apogee to AbbVie for nearly $11 billion, the hardest part of being a CEO, what it takes to build a great team and culture, Michael's three rules for first-time biotech CEOs, and more.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Running Through Walls?
This episode is 37 minutes long.
When was this Running Through Walls episode published?
This episode was published on September 14, 2026.
Can I download this Running Through Walls episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.